Testosterone supplementation in aging men and women: Possible impact on cardiovascular-renal disease

American Journal of Physiology - Renal Physiology

Volumn 289, Issue 5 58-5, 2005, Pages

  Reckelhoff, Jane F ^a   Yanes, Licy L ^a   Iliescu, Radu ^a   Fortepiani, Lourdes A ^a   Granger, Joey P ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Androgen receptor; Angiotensin II; Cytokines; Endothelin; Oxidative stress

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANGIOTENSIN; CYTOKINE; DARUSENTAN; ENDOTHELIN; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PHOSPHODIESTERASE V INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SILDENAFIL; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA;

AGED; AGING; BLOOD PRESSURE REGULATION; BONE STRENGTH; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CYTOKINE PRODUCTION; ERECTILE DYSFUNCTION; FEMALE; GLOMERULUS FILTRATION RATE; HORMONE ACTION; HUMAN; KIDNEY PROXIMAL TUBULE; LIBIDO; MALE; MEAN ARTERIAL PRESSURE; MUSCLE MASS; NONHUMAN; OSTEOPOROSIS; OVARIECTOMY; OXIDATIVE STRESS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SPONTANEOUSLY HYPERTENSIVE RAT; TESTOSTERONE BLOOD LEVEL; VASOCONSTRICTION;

EID: 26844573364     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00034.2005     Document Type: Review

References (87)

1. Agarwal R. Chronic kidney disease is associated with oxidative stress independent of hypertension. Clin Nephrol 61: 377-383, 2004.
2. Ala-Fossi SL, Maenpaa J, Aine R, and Punnonen R. Ovarian testosterone secretion during perimenopause. Maturitas 29: 239-245, 1998.
3. Alexander BT, Cockrell KL, Rinewalt AN, Herrington JN, and Granger JP. Enhanced renal expression of preproendothelin mRNA during chronic angiotensin II hypertension. Am J Physiol Regul Integr Comp Physiol 280: R1388-R1392, 2001.
4. Baltatu O, Cayla C, Iliescu R, Andrew D, Jordan C, and Bader M. Abolition of hypertension-induced end organ damage by androgen receptor blockade in transgenic rats harboring the mouse ren-2 gene. J Am Soc Nephrol 13: 2681-2687, 2002.
5. Barton M, Lattmann T, d'Ushio LV, Luscher TF, and Shaw S. Inverse regulation of endothelin-1 and nitric oxide metabolites in tissue with aging: implications for the age-dependent increase of cardiorenal disease. J Cardiovasc Pharmacol 36: S153-S156, 2000.
6. Baylis C. Age-dependent glomerular damage in the rat. Dissociation between glomerular injury and both glomerular hypertension and hypertrophy. Male gender as a primary risk factor. J Clin Invest 94: 1823, 1994.
7. Burl VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, and Labarthe D. Prevalence of hypertension in the US adult population. Results from the third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 25: 305-313, 1995.
8. Chen YF, Naftilan AJ, and Oparil S. Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. Hypertension 19: 456-463, 1992.
9. Cherrier MM, Matsumoto AM, Amory JK, Ahmed S, Bremner W, Peskind ER, Raskind MA, Johnson M, and Craft S. The role of aromatization in testosterone supplementation. Effects on cognition in older men. Neurology 64: 290-296, 2005.
10. Corrales JJ, Burgo RM, Garca-Berrocal B, Almeida M, Alberca I, Gonzalez-Buitrago JM, Orfao A, and Miralles JM. Partial androgen deficiency in aging type 2 diabetic men and its relationship to glycemic control. Metabolism 53: 666-672, 2004.
11. Crofton JT and Share L. Gonadal hormones modulate deoxycorticosterone- salt hypertension in male and female rats. Hypertension 29: 494-499, 1997.
12. Culig Z. Androgen receptor cross-talk with cell -signalling pathways. Growth Factors 22: 179-184, 2004.
13. Davison S, Thipphawong J, Blanchard J, Liu K, Morishinge R, Gonda I, Okikawa J, Adams J, Evans A, Otulana B, and Davis S. Pharmacokinetics and acute safety of inhaled testosterone in postmenopausal women. J Clin Pharmacol 45: 177-184, 2005.
14. Delfino FJ, Boustead JN, Fix C, and Walker WH. NF-κB and TNF-α stimulate androgen receptor expression in Sertoli cells. Mol Cell Endocrinol 201: 1-12, 2003.
15. Diamanti-Kandarakis E, Spina G, Kouli C, and Migdalis I. Increase in endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin treatment. J Clin Endocrinol Metab 86: 4666-4673, 2001.
16. Duerrschmidt N, Wippich N, Goettsch W, Broemme HJ, and Morawietz H. Endothelin-1 induces NAD(P)H oxidase in human endothelial cells. Biochem Biophys Res Commun 269: 713-717, 2000.
17. Elijovich F, Laffer CL, Schiffrin EL, Gavras H, and Amador E. Endothelin-aldosterone interaction and proteinuria in low-renin hypertension. J Hypertens 22: 573-582, 2004.
18. Ellison KE, Ingelfinger JR, Pivor M, and Dzau VJ. Androgen regulation of rat renal angiotensinogen messenger RNA expression. J Clin Invest 83: 1941-1945, 1989.
19. Feldman H, Longcope C, Derby C, Johannes C, Araujo A, Coviello A, Bremner W, and McKinlay J. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 87: 589-598, 2002.
20. Ferrini R and Barrett-Conner E. Sex hormones and age-a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol 147: 750-754, 1998.
21. Fortepiani LA and Reckelhoff JF. Tempol from birth abrogates the sex difference in the depressor response to tempol in SHR. J Hypertens. In press.
22. Fortepiani LA, Yanes L, Zhang H, Racusen LC, and Reckelhoff JF. Role of androgens in mediating renal injury in aging SHR. Hypertension 42: 952-955, 2003.
23. Fortepiani LA, Zhang H, Racusen LC, Roberts LJII, and Reckelhoff JF. Characterization of an animal model of postmenopausal hypertension in SHR. Hypertension 41: 460-463, 2003.
24. Gandolfo MT, Verzola D, Salvatore F, Gianiorio G, Procopio V, Romagnoli A, Giannoni M, and Garibotto G. Gender and the progression of chronic renal diseases: does apoptosis make the difference? Minerva Urol Nefrol 56: 1-14, 2004.
25. Goddard J, Eckart C, Johnston NR, Cumming AD, Rankin AJ, and Webb DJ. Endothelin A receptor antagonism an angiotensin-converting enzyme inhibition are synergistic via an endothelin B receptor-mediated and nitric oxide-dependent mechanism. J Am Soc Nephrol 15: 2601-2610, 2004.
26. Goddard J, Johnston NR, Hand MF, Cumming AD, Rabelink TJ, Ranki AJ, and Webb DJ. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin-receptor blockade. Circ 109: 1186-1193, 2004.
27. Hall YN, Fuentes EF, Chertow GM, and Olson JL. Race/ethnicity and disease severity in IgA nephropathy. BMC Nephrol 5: 10, 2004.
28. Harman S, Metter E, Tobin J, Pearson J, and Blackman M. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 86: 724-731, 2001.
29. 1 receptor and salt sensitivity. Hypertension 42: 1157-1163, 2003.
30. Hartmann BW, Kirchengast S, Albrecht A, Laml T, Soregi G, and Huber JC. Androgen serum levels in women with premature ovarian failure compared to fertile and menopausal controls. Gynecol Obstet Invest 44: 127-131, 1997.
31. 2-isoprostane excretion in migraine. Clin Sci (Lond) 102: 39-43, 2002.
32. Hinojosa-Laborde C, Lange DL, and Haywood JR. Role of female sex hormones in the development and reversal of Dahl hypertension. Hypertension 35: 484-489, 2000.
33. Holley JL. The hypothalamic-pituitary axis in men and women with chronic kidney disease. Adv Chronic Kidney Dis 11: 337-341, 2004.
34. Ide T, Tsutsui H, Ohashi N, Hayashidani S, Suematsu N, Tsuchihyasm M, Tamai H, and Takeshita A. Greater oxidative stress in healthy young men compared with premenopausal women. Arterioscler Thromb Vasc Biol 22: 1239-1242, 2002.
35. James GD, Sealey JE, Muller F, Alderman M, Madhavan S, and Laragh JH. Renin relationship to sex, race and age in normotensive population. J Hypertens 4: S387-S389, 1986.
36. Ji H, Menini S, Mok K, Zheng W, Pesce C, Kim J, Mulroney S, and Sandberg K. Gonadal steroid regulation of renal injury in renal wrap hypertension. Am J Physiol Renal Physiol 288: F513-F520, 2005.
37. Jiroutek MR, Chen MH, Johnston CC, and Longcope C. Changes in reproductive hormones and sex hormone-binding globulin in a group of postmenopausal women measured over 10 years. Menopause 5: 90-94, 1998.
38. Johansen KL. Treatment of hypogonadism in men with chronic kidney disease. Adv Chronic Kidney Dis 11: 348-356, 2004.
39. Johansen KL. Testosterone metabolism and replacement therapy in patients with end stage renal disease. Semin Dial 17: 202-208, 2004.
40. Kaehler J, Sill B, Koester R, Mittmann C, Orzechowski HD, Muenzel T, and Meinertz T. Endothelin-1 mRNA and protein in vascular wall cells is increased by reactive oxygen species. Clin Sci (Lond) 103, Suppl 48: 176S-178S, 2002.
41. Khoury S, Yarows SA, O'Brien TK, and Sowers JR. Ambulatory blood pressure monitoring in a nonacademic setting. Effects of age and sex. Am J Hypertension 5: 616-623, 1992.
42. Kicman AT, Bassindale T, Cowan DA, Dale S, Hutt AJ, and Leeds AR. Effect of androstenedione ingestion on plasma testosterone in young women; a dietary supplement with potential health risks. Clin Chem 49: 167-169, 2003.
43. Kimura N, Mizokami A, Oonuma T, Sasano H, and Nagura H. Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues. J Histochem Cytochem 41: 671-678, 1993.
44. Krug E and Berga SL. Postmenopausal hyperthecosis: functional dysregulation of androgenesis in climacteric ovary. Obstet Gynecol 99: 893-897, 2002.
45. Laughlin GA, Barrett-Connor E, Kritz-Silverstein D, and von Muhlen D. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Endocrinol Metab 85: 645-651, 2000.
46. 1 receptor and its regulation of anion secretion in the rat epididymis. Cell Biol Int 26: 117-122, 2002.
47. Matsuzaki K, Arai T, Inumaru T, Mihori M, Momose T, Sano M, Koide K, and Shimizu N. Androgen metabolism in cultured rat renal inner medullary collecting duct (IMCD) cells. Steroids 63: 105-110, 1998.
48. Miller JA, Anacta LA, and Cattran C. Impact of gender on the renal response to angiotensin II. Kidney Int 55: 278-285, 1999.
49. Modlinger P, Wilcox C, and Asian S. Nitric oxide, oxidative stress and progression of chronic renal failure. Semin Nephrol 24: 354-365, 2004.
50. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz H, August M, Kleschyov A, Tsilimingas N, Walter F, Forstermann U, Meinertz T, Griendling K, and Munzel T. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90: E58-E65, 2002.
51. Muller V, Losonczy G, Heemann U, Vannay A, Fekete A, Reusz G, Tulassay T, and Szabo A. Sexual dimorphism in renal ischemia-reperfusion injury in rats: possible role of endothelin. Kidney Int 62: 1364-1371, 2002.
52. Neirman DM and Mechanick JI. Hypotestosteronemia in chronically critically ill men. Crit Care Med 27: 2418-2421, 1999.
53. Neugarten J, Acharya A, and Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol 11: 319-329, 2000.
54. Neugarten J, Kasiske B, Silbiger SR, and Nyengaard JR. Effects of sex on renal structure. Nephron 90: 139-144, 2002.
55. 1 receptor gene expression in vitro and in vivo. Circulation 97: 2197-2201, 1998.
56. Ortmann J, Amann K, Brandes R, Kretzler M, Munter K, Parekh N, Traupe T, Lange M, Lattmann T, and Barton M. Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition. Hypertension 44: 974-981, 2004.
57. Overlie I, Moen MH, Morkrid L, Skjaeraasen JS, and Holte A. The endocrine transition around menopause-a five years prospective study with profiles of gonadotropins, estrogens, androgens and SHBG among healthy women. Acta Obstet Gynecol Scand 78: 642-647, 1999.
58. Phillips GBJT, Resnick LM, Barbagallo M, Laragh JH, and Sealey JE. Sex hormones and hemostatic factors for coronary heart disease in men with hypertension. J Hypertension 11: 699-702, 1993.
59. Quan A, Chakravarty S, Chen JK, Chen JC, Loleh S, Saini N, Harris R, Capdevila J, and Quigley R. Androgens augment proximal tubule transport. Am J Physiol Renal Physiol 287: F452-F459, 2004.
60. Quinkler M, Bumke-Vogt C, Meyer B, Bahr V, Oelkers W, and Diederich S. The human kidney is a progesterone-metabolizing and androgen-producing organ. J Clin Endocrinol Metab 88: 2803-2809, 2003.
61. Rajagopalan K, Kurz S, Munzel T, Tarpey M, Freeman B, Griendling K, and Harrison D. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97: 1916-1923, 1996.
62. Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension 37: 1199-1208, 2001.
63. Reckelhoff JF, Hennington B, Moore A, Blanchard E, and Cameron J. Gender differences in the renal nitric oxide (NO) system. Dissociation between expression of endothelial NO synthase and renal hemodynamic response to NO synthase inhibition. Am J Hypertens 11: 97-104, 1998.
64. Reckelhoff JF, Hennington BS, Kanji V, Racusen LC, Schmidt AM, Yan SD, Morrow JD, Roberts LJ II, and Salahudeen A. Chronic aminoguanidine attenuates renal dysfunction and injury in aging rats. Am J Hypertens 12: 492-498, 1999.
65. 2-isoprostanes in aging kidneys. Am J Physiol Regul Integr Comp Physiol 274: R767-R774, 1998.
66. Reckelhoff JF and Manning, RD Jr. Role of endothelial-derived nitric oxide in the control of the renal microvasculature in aging male rats. Am J Physiol Regul Integr Comp Physiol 265: R1126-R1131, 1993.
67. Reckelhoff JF and Romero JC. Role of oxidative stress in angiotensin-induced hypertension. Am J Physiol Regul Integr Comp Physiol 284: R893-R912, 2003.
68. Reckelhoff JF, Samsell L, Dey R, Racusen L, and Baylis C. The effect of aging on glomerular hemodynamics in the rat. Am J Kidney Dis 20: 70-75, 1992.
69. Reckelhoff JF, Zhang H, and Granger JP. Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats. Hypertension 31: 435-439, 1998.
70. Reckelhoff JF, Zhang H, and Srivastava K. Gender differences in the development of hypertension in SHR: role of the renin-angiotensin system. Hypertension 35: 480-483, 2000.
71. 2- isoprostanes in rats. Hypertension 35: 476-479, 2000.
72. 2- isoprostanes unveils profound oxidative stress in aged rats. Biochem Biophys Res Commun 87: 254-256, 2001.
73. Rowland NE and Fregly MJ. Role of gonadal hormones in hypertension in the Dahl salt-sensitive rat. Clin Exp Hypertens A 14: 367-375, 1992.
74. Schmidt A, Luger A, and Walter Horl. Sexual hormone abnormalities in male patients with renal failure. Nephrol Dial Transplant 17: 368-371, 2002.
75. Schultheiss D, Machtens S, and Jonas U. Testosterone therapy in the ageing male: what about the prostate? Andrologia 36: 355-365, 2004.
76. Silbiger SR and Neugarten J. The role of gender in the progression of renal disease. Adv Ren Replace Ther 10: 3-14, 2003.
77. Sluijmer A, Heineman M, Konstaal J, Theunissen P, dejong F, and Evers J. Relationship between ovarian production of estrone, estradiol, testosterone and androstenedione and the ovarian degree of stromal hyperplasia in postmenopausal women. Menopause 3: 207-216, 1998.
78. Sorokin A and Kohan D. Physiology and pathology of endothelin-1 in renal mesangium. Am J Physiol Renal Physiol 285: F579-F589, 2003.
79. Spark RF. Intrinsa fails to impress FDA advisory panel. Int J Impot Res 17: 283-284, 2005.
80. Terada N, Arai Y, Kinukawa N, Yoshimura K, and Terai A. Risk factors for renal cysts. BJU Int 93: 1300-1302, 2004.
81. Turner H and Wass J. Declining gonadal function in men with chronic disease. Clin Endocrinol 47: 379-403, 1997.
82. Van Kesteren PJ, Kooistra T, Lansink M, van Kamp GJ, Asscheman H, Gooren LJ, Emeis JJ, Vischer UM, and Stehouwer CD. The effects of sex steroids on plasma levels of marker proteins of endothelial cell functioning. Thromb Haemost 79: 1029-1033, 1998.
83. Vermeiden A, Rubens R, and Verdonck L. Testosterone secretion and metabolism in male senescence. J Clin Endocrinol Metab 34: 730-735, 1979.
84. Wagner A, Schroeter M, and Hecker M. 17β-Estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB J 15: 2121-2130, 2001.
85. Weinberger M. Sodium and blood pressure 2003. Curr Opin Cardiol 19: 353-356, 2004.
86. Wiinber N, Hoegholm A, Christensen H, Bang L, Mikkelsen K, Nielsen P, Svendsen T, Kampmann J, Madsen N, and Bentzon M. 24-h Ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. Am J Hypertens 8: 978-986, 1995.
87. Yanes LL, Romero D, Cucchiarelli V, Fortepiani LA, Gomez-Sanchez C, Santacruz F, and Reckelhoff JF. Role of endothelin in mediating postmenopausal hypertension in a rat model. Am J Physiol Regul Integr Comp Physiol 288: R229-R233, 2005.